Bvf Inc Eq Rx, Inc. Transaction History

Bvf Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.94 - $5.99 $4.36 Million - $27.8 Million	-4,640,340 Reduced 43.58%	6,008,187 $29.7 Million
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.69 $4.41 Million - $7.84 Million	-1,377,043 Reduced 11.45%	10,648,527 $49.9 Million
Q1 2022 May 16, 2022	BUY	$2.8 - $7.39 $11.7 Million - $30.8 Million	4,165,900 Added 53.0%	12,025,570 $49.7 Million
Q4 2021 Feb 14, 2022	BUY	$5.92 - $9.98 $46.5 Million - $78.4 Million	7,859,670 New	7,859,670 $53.6 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.